NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
The Promise of TMS Therapy for Fibromyalgia: Insights from Recent Research
Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, and cognitive difficulties. Traditional treatments often provide limited relief, leaving [...]
TMS Therapy for Parkinson’s Disease and More at Countryside Neurology
A recent article from the Michael J. Fox Foundation highlights the promising use of Transcranial Magnetic Stimulation (TMS) in treating [...]
Unveiling the Power of TMS Therapy Across Conditions
A recent study published in Frontiers in Neurology has shed new light on the effectiveness of Transcranial Magnetic Stimulation (TMS) [...]
Exploring TMS Therapy: An Effective Alternative When Medications Fall Short
A recent Q&A article on Medical Xpress discusses the growing recognition of Transcranial Magnetic Stimulation (TMS) therapy as a powerful [...]
TMS Therapy: A Promising Solution for Depression at Countryside Neurology
A recent article from Neuroscience News highlights the growing success and potential of Transcranial Magnetic Stimulation (TMS) therapy in treating [...]
TMS Therapy Offers Hope for New Moms Battling Depression
Transcranial Magnetic Stimulation (TMS) therapy is gaining recognition as a promising treatment for depression, especially among new mothers. A recent [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social